罗氏Roche Holdings（RHHBY）2023年年度报告「OTC」.pdf

1、Annual Report 2023Sustainable innovation at our coreInnovation is at the core of everything we do.We are committed to transform lives.Pushing boundaries,wepursue ground-breaking solutions across all our functions.Doingnow what patients need next,we look ahead to create a healthy and stable future fo

2、r people and the planet.With pharmaceuticals and diagnostics under one roof,we are uniquely positioned to improve care along the patient journey.By investing in cutting-edge research and collaborative partnerships,we continue totransform ideas into life-changing solutions for people and communitiesw

3、orldwide.2|Contents Letters to shareholders Sustainability Report How we contribute Corporate Governance Remuneration ReportLetters to shareholders 4 Sustainability Report 14 How we contribute 96Corporate Governance 122 Remuneration Report 148C Report 2023|Roche 34|Contents Letters to shareholders S

4、ustainability Report How we contribute Corporate Governance Remuneration ReportLetters to shareholdersLetters to shareholders|Roche 5Dr Severin Schwan6|Contents Letters to shareholders Sustainability Report How we contribute Corporate Governance Remuneration ReportDear ShareholdersAt Roche,the year

5、2023 was marked by significant management changes.I am very pleased that my successor as CEO,Thomas Schinecker,and his leadership team have already embarked on a series of important initiatives.Roche is characterised by itsability to combine continuity and change.We remain committed to our values an

6、d our strategy,and at the same time,we evolve as an organisation,and initiate necessary changes accordingly.We are convinced that our strategy,which is focused on innovation in pharmaceuticals and diagnostics,ensures we remain in a strong position.Our consistent ability to successfully bring new pro